A detailed history of Vestmark Advisory Solutions, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 27,194 shares of NVO stock, worth $3.89 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
27,194
Previous 27,629 1.57%
Holding current value
$3.89 Million
Previous $2.86 Million 22.15%
% of portfolio
0.16%
Previous 0.15%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $44,417 - $59,125
-435 Reduced 1.57%
27,194 $3.49 Million
Q4 2023

Feb 06, 2024

SELL
$87.78 - $105.45 $156,950 - $188,544
-1,788 Reduced 6.08%
27,629 $2.86 Million
Q3 2023

Nov 06, 2023

SELL
$90.94 - $199.54 $434,511 - $953,402
-4,778 Reduced 13.97%
29,417 $2.68 Million
Q2 2023

Aug 07, 2023

BUY
$155.98 - $172.65 $155,044 - $171,614
994 Added 2.99%
34,195 $5.53 Million
Q1 2023

May 09, 2023

SELL
$132.34 - $159.14 $330,717 - $397,690
-2,499 Reduced 7.0%
33,201 $5.28 Million
Q4 2022

Jan 20, 2023

SELL
$102.55 - $135.33 $12,511 - $16,510
-122 Reduced 0.34%
35,700 $0
Q3 2022

Nov 03, 2022

SELL
$95.28 - $116.93 $263,544 - $323,428
-2,766 Reduced 7.17%
35,822 $3.57 Million
Q2 2022

Aug 04, 2022

BUY
$103.24 - $121.81 $1.1 Million - $1.3 Million
10,700 Added 38.37%
38,588 $4.3 Million
Q1 2022

Apr 27, 2022

SELL
$93.1 - $112.54 $229,770 - $277,748
-2,468 Reduced 8.13%
27,888 $3.1 Million
Q4 2021

Jan 31, 2022

BUY
$95.88 - $117.08 $3,259 - $3,980
34 Added 0.11%
30,356 $3.4 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $591,193 - $746,659
7,003 Added 30.03%
30,322 $2.91 Million
Q2 2021

Aug 09, 2021

BUY
$67.66 - $84.76 $336,202 - $421,172
4,969 Added 27.08%
23,319 $1.95 Million
Q1 2021

May 10, 2021

SELL
$67.06 - $75.82 $55,324 - $62,551
-825 Reduced 4.3%
18,350 $1.24 Million
Q4 2020

Feb 04, 2021

BUY
$63.89 - $73.8 $20,828 - $24,058
326 Added 1.73%
19,175 $1.34 Million
Q3 2020

Oct 19, 2020

BUY
$63.69 - $70.22 $85,026 - $93,743
1,335 Added 7.62%
18,849 $1.31 Million
Q2 2020

Aug 13, 2020

SELL
$58.54 - $67.94 $22,713 - $26,360
-388 Reduced 2.17%
17,514 $1.15 Million
Q1 2020

May 06, 2020

BUY
$49.46 - $64.78 $47,283 - $61,929
956 Added 5.64%
17,902 $1.08 Million
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $215,544 - $251,857
4,323 Added 34.25%
16,946 $981,000
Q3 2019

Nov 05, 2019

BUY
$47.54 - $53.43 $104,207 - $117,118
2,192 Added 21.01%
12,623 $653,000
Q2 2019

Aug 20, 2019

BUY
$46.79 - $52.47 $36,730 - $41,188
785 Added 8.14%
10,431 $532,000
Q1 2019

May 14, 2019

BUY
$46.36 - $52.63 $447,188 - $507,668
9,646 New
9,646 $505,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $323B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Vestmark Advisory Solutions, Inc. Portfolio

Follow Vestmark Advisory Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.